Amarin Corp. (AMRN) Tops Q4 EPS by 4c, Revs Beat; Reaffirms

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Amarin Corp. (AMRN) Tops Q4 EPS by 4c, Revs Beat; Reaffirms

Amarin Reports Record Fourth Quarter and Full Year 2019 Financial Results and Provides Update on Operations

February 25, 2020 4:06 PM EST

Record Revenue of $429.8 Million and $143.3 Million for Full Year and Fourth Quarter 2019  

Launch Commenced of VASCEPA® as First and Only Drug with Its New Cardiovascular Risk Reduction Indication

Management to Host Conference Call at 4:30 p.m. ET Today

DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today announced financial results for the quarter and year ended December 31, 2019 and provided an update on company operations.

Key Amarin recent achievements... More